Modulating Cellular Response and Angiogenesis in Oral Surgery: The Strategic Application of Advanced PRF Derivatives in Contemporary Implant-Perio Therapy

Abstract

Platelet-Rich Fibrin (PRF) has emerged as one of the most versatile regenerative biomaterials in contemporary periodontology and implantology due to its autologous origin, ease of preparation, biocompatibility, and ability to promote accelerated healing. As oral surgical procedures increasingly prioritize minimally invasive techniques and biologically driven regeneration, PRF scaffolds play a pivotal therapeutic role in enhancing clinical outcomes. This paper examines the regenerative mechanisms, clinical applications, and therapeutic benefits of PRF in optimizing oral surgery outcomes. PRF provides a natural fibrin matrix rich in platelets, leukocytes, cytokines, and growth factors such as PDGF, TGF-β, IGF, and VEGF, which collectively stimulate angiogenesis, osteogenesis, fibroblast proliferation, and soft tissue remodeling. Its slow and sustained release of bioactive molecules supports early wound healing, improves graft stabilization, and promotes greater tissue integration.